Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868462 · ClinicalTrials.gov registry record · NA
Optos P200TE Agreement and Precision Study
A NA study, sponsored by Optos.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT03868462 is a NA study that has completed, run by Optos. The registered enrollment target is 137 participants.
The verdict
NCT03868462, a NA study, has completed, sponsored by Optos.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
This study is a prospective comparative, randomized, single center study to assess agreement and precision of the Optos P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
Interventions
- DEVICE Predicate Device
- DEVICE Optos P200TE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2019-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03868462
The ClinicalTrials.gov registry entry for NCT03868462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optos, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Predicate Device is the first listed.
NCT03868462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03868462 about?
NCT03868462 is a clinical study titled "Optos P200TE Agreement and Precision Study". This study is a prospective comparative, randomized, single center study to assess agreement and precision of the Optos P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.
What is the current status of trial NCT03868462?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2019-02-11. Estimated completion is 2019-09-16.
What interventions are being tested in trial NCT03868462?
The interventions under investigation include: Predicate Device (DEVICE), Optos P200TE (DEVICE).
Who is sponsoring clinical trial NCT03868462?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.